INBS logo

Intelligent Bio Solutions Inc. (INBS)

Profile

Full Name

Intelligent Bio Solutions Inc.

Ticker

NASDAQ: INBS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 23, 2020

Indexes

Not included

Website

https://ibs.inc

Employees

50

Key Details

Price

$1.41(-25.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.05M(-1.91% YoY)

Annual EPS

-$2.00(+68.65% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.41
    INBS price is $1.41

    30-Day Relative Volume

    8.35
    INBS 30-day relative volume is 8.35

    Price Performance

    Price Most recent change

    -25%
    INBS price was down -25% on Sep 17, 2025

    Price YTD change

    +0.71%
    INBS price is up +0.71% since January 1st

    Price 1-year change

    -43.15%
    INBS price is down -43.15% year-on-year

    Price 3-year change

    -98.73%
    INBS price is down -98.73% over the past 3 years

    Price Range

    Price All-time high

    $3417.60
    INBS price is currently -99.96% below its historical high of $3417.60

    Price 3-year low

    $1.00
    INBS price is currently +41.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $12.66M
    INBS market capitalization is $12.66 million

    Market cap 3-year change

    +84.57%
    INBS market capitalization is up +84.57% over the past 3 years

    Market cap All-time high

    $124.31M
    INBS market capitalization is currently -89.81% below its historical high of $124.31 million

    Market cap sector rank

    18.04%
    INBS market capitalization is higher than 18.04% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +111.29%
    INBS shares outstanding is up +111.29% year-on-year

    Shares Outstanding 3-Year Change

    +14382.58%
    INBS shares outstanding is up +14382.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.01
    INBS beta is 1.01

    200-day SMA

    $1.64
    INBS price is currently -13.86% below its 200-day simple moving average

    50-day SMA

    $1.66
    INBS price is currently -15.19% below its 50-day simple moving average

    RSI

    40.93
    INBS 14-day relative strength index is 40.93

    Volume

    8.35
    INBS 30-day relative volume is 8.35

    ATR

    $0.15
    INBS average true range is $0.15

    10-day Historical Volatility

    154.64%
    INBS 10-day historical volatility is 154.64%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.05M
    INBS annual revenue is $3.05 million

    Revenue Analysts estimate

    $26.29M
    INBS annual revenue is currently -88.39% lower than the consensus analysts' forecast

    Revenue 1-year change

    -1.91%
    INBS annual revenue is down -1.91% year-on-year

    Revenue Sector rank

    41.1%
    INBS annual revenue is higher than 41.1% of companies in Healthcare sector

    EPS

    EPS

    -$2.00
    INBS annual earnings per share is -$2.00

    EPS Analysts estimate

    $0.35
    INBS annual earnings per share is currently -671.43% lower than the consensus analysts' forecast

    EPS 1-year change

    +68.65%
    INBS annual earnings per share is up +68.65% year-on-year

    EPS Sector rank

    37.28%
    INBS annual earnings per share is higher than 37.28% of companies in Healthcare sector

    Profit

    Gross profit

    $39.00K
    INBS annual gross profit is $39.00 thousand

    Gross margin

    1.28%
    INBS annual gross profit margin is 1.28%

    Operating profit

    -$11.24M
    INBS annual operating income is -$11.24 million

    Operating margin

    -368.27%
    INBS annual operating profit margin is -368.27%

    Net income

    -$10.60M
    INBS annual net profit is -$10.60 million

    Net margin

    -347.42%
    INBS annual net profit margin is -347.42%

    Expenses

    Total expenses

    $13.62M
    INBS annual total expenses is $13.62 million

    Operating expenses

    $11.28M
    INBS annual total operating expenses is $11.28 million

    Cost of goods sold

    $3.01M
    INBS annual cost of goods sold is $3.01 million

    Selling, general & administrative expenses

    $0.00
    INBS annual SGA is $0.00

    Depreciation and amortization

    $1.21M
    INBS annual depreciation & amortization is $1.21 million

    Interest expense

    $0.00
    INBS annual interest expense is $0.00

    Income tax

    $0.00
    INBS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$11.24M
    INBS annual earnings before interest & taxes is -$11.24 million

    EBITDA

    -$10.03M
    INBS annual EBITDA is -$10.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $8.27M
    INBS annual total assets is $8.27 million

    Non current assets

    $4.19M
    INBS annual long term assets is $4.19 million

    Current assets

    $4.07M
    INBS annual total current assets is $4.07 million

    Cash and cash equivalents

    $1.02M
    INBS annual cash & cash equivalents is $1.02 million

    Accounts receivable

    $594.60K
    INBS annual accounts receivable is $594.60 thousand

    Inventory

    $635.20K
    INBS annual inventory is $635.20 thousand

    Liabilities

    Total liabilities

    $5.45M
    INBS annual total liabilities is $5.45 million

    Long term liabilities

    $100.10K
    INBS annual total long term liabilities is $100.10 thousand

    Current liabilities

    $5.35M
    INBS annual total current liabilities is $5.35 million

    Accounts payable

    $897.30K
    INBS annual accounts payable is $897.30 thousand

    Debt

    Total debt

    $281.80K
    INBS annual total debt is $281.80 thousand

    Total debt 1-year change

    -67.66%
    INBS annual total debt is down -67.66% year-on-year

    Long term debt

    $0.00
    INBS annual long term debt is $0.00

    Short term debt

    $281.80K
    INBS annual short term debt is $281.80 thousand

    Equity & Capital

    Shareholders equity

    $3.00M
    INBS annual stockholders equity is $3.00 million

    Book value

    $3.00M
    INBS annual book value is $3.00 million

    Retained earnings

    -$62.53M
    INBS annual retained earnings is -$62.53 million

    Working capital

    -$1.28M
    INBS annual working capital is -$1.28 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.68M
    INBS annual cash flow from operations is -$9.68 million

    Cash from operations 1-year change

    -1.1%
    INBS annual cash flow from operations is down -1.1% year-on-year

    Cash from investing

    -$231.80K
    INBS annual cash flow from investing activities is -$231.80 thousand

    Cash from investing 1-year change

    -4.7%
    INBS annual cash flow from investing activities is down -4.7% year-on-year

    Cash from financing

    $4.60M
    INBS annual cash flow from financing activities is $4.60 million

    Cash from financing 1-year change

    -68.42%
    INBS annual cash flow from financing activities is down -68.42% year-on-year

    CAPEX

    CAPEX

    $231.80K
    INBS annual capital expenditures is $231.80 thousand

    CAPEX 1-year change

    +4.7%
    INBS annual capital expenditures is up +4.7% year-on-year

    Free Cash Flow

    Free cash flow

    -$9.91M
    INBS annual free cash flow is -$9.91 million

    Free cash flow 1-year change

    -1.19%
    INBS annual free cash flow is down -1.19% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    1.28%
    INBS annual gross profit margin is 1.28%

    Operating margin

    -368.27%
    INBS annual operating profit margin is -368.27%

    Net margin

    -347.42%
    INBS annual net profit margin is -347.42%

    ROA & ROE

    ROA

    -96.22%
    INBS annual return on assets is -96.22%

    ROE

    -192.87%
    INBS annual return on equity is -192.87%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    INBS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    INBS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.23
    INBS price to book ratio is 4.23

    PB ratio Sector rank

    74.35%
    INBS price to book ratio is higher than 74.35% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.15
    INBS price to sales ratio is 4.15

    PS ratio Sector rank

    53.22%
    INBS price to sales ratio is higher than 53.22% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $11.92M
    INBS enterprise value is $11.92 million

    Enterprise value Sector rank

    23.69%
    INBS enterprise value is higher than 23.69% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.19
    INBS EV/EBITDA is -1.19

    EV/EBITDA Sector rank

    44.3%
    INBS EV/EBITDA is higher than 44.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.76
    INBS annual current ratio is 0.76

    Quick ratio

    0.64
    INBS annual quick ratio is 0.64

    Leverage

    Debt to equity

    0.09
    INBS annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    INBS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    INBS piotroski f-score is 4

    Altman Z-Score

    -13.50
    INBS altman z-score is -13.50

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with INBS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Intelligent Bio Solutions Inc.?
    • Does Intelligent Bio Solutions Inc. pay dividends?
    • What sector is Intelligent Bio Solutions Inc. in?
    • What industry is Intelligent Bio Solutions Inc. in?
    • What country is Intelligent Bio Solutions Inc. based in?
    • When did Intelligent Bio Solutions Inc. go public?
    • Is Intelligent Bio Solutions Inc. in the S&P 500?
    • Is Intelligent Bio Solutions Inc. in the NASDAQ 100?
    • Is Intelligent Bio Solutions Inc. in the Dow Jones?
    • When was Intelligent Bio Solutions Inc.'s last earnings report?
    • When does Intelligent Bio Solutions Inc. report earnings?

    What is the ticker symbol for Intelligent Bio Solutions Inc.?

    The ticker symbol for Intelligent Bio Solutions Inc. is NASDAQ:INBS

    Does Intelligent Bio Solutions Inc. pay dividends?

    No, Intelligent Bio Solutions Inc. does not pay dividends

    What sector is Intelligent Bio Solutions Inc. in?

    Intelligent Bio Solutions Inc. is in the Healthcare sector

    What industry is Intelligent Bio Solutions Inc. in?

    Intelligent Bio Solutions Inc. is in the Medical Devices industry

    What country is Intelligent Bio Solutions Inc. based in?

    Intelligent Bio Solutions Inc. is headquartered in United States

    When did Intelligent Bio Solutions Inc. go public?

    Intelligent Bio Solutions Inc.'s initial public offering (IPO) was on December 23, 2020

    Is Intelligent Bio Solutions Inc. in the S&P 500?

    No, Intelligent Bio Solutions Inc. is not included in the S&P 500 index

    Is Intelligent Bio Solutions Inc. in the NASDAQ 100?

    No, Intelligent Bio Solutions Inc. is not included in the NASDAQ 100 index

    Is Intelligent Bio Solutions Inc. in the Dow Jones?

    No, Intelligent Bio Solutions Inc. is not included in the Dow Jones index

    When was Intelligent Bio Solutions Inc.'s last earnings report?

    Intelligent Bio Solutions Inc.'s most recent earnings report was on August 15, 2025

    When does Intelligent Bio Solutions Inc. report earnings?

    The next expected earnings date for Intelligent Bio Solutions Inc. is November 7, 2025
    On this page